I N T E R V I E W
of people at their companies who are qualified to do it . Veeda envisage to become the CRO that can position itself as a full-service “ general contractor ” of choice for biotech companies , bringing relationships , access to services , and strategic perspective , can become an invaluable development partner .
How does your company approach R & D in the biopharma space ? Can you highlight any recent breakthroughs or advancements in your pipeline that you find particularly promising ?
Veeda ’ s R & D team recognizes its role as an integrator of point solutions that drive speed , quality , and stakeholder experience in product development — and build the capabilities to orchestrate the use of point solutions flawlessly . Veeda Biopharma further position itself as an end-to-end strategic partners — that is , from asset strategy to launch .
Veeda Biopharma ’ s Discovery Biology is actively working to establish various assays in order to support the PROTAC and Biologics / Biosimilar ’ s research and development . Developing platform methods are essential for providing rapid analytical support to biopharma industry and this mandates research and development with continuous upskilling of technical force . Veeda Biopharma now holds ready-package for physico-chemical characterization
of leading monoclonal antibodies , bispecific antibodies , peptides and other modalities . We have also established HOS laboratory equipped with globally recognized instruments , delivering high quality structural information of biopharmaceuticals . Complexity , an integral part of drug development , is where deciphering solutions are appreciated and characterization of fusion proteins has paved way for innovations .
Veeda Biopharma continues to look at unharnessed technologies such as advanced mass spectrometry and biophysical technologies to broaden the analytical outlook for biopharma industry .
How does your company navigate the complex regulatory environment in the biopharma industry ? Strategies to ensure compliance with regulatory requirements while maintaining agility in product development ?
Veeda is an independent Indian CRO with 19 + years of experience and has conducted over 3800 + studies working with over 200 biopharmaceutical companies around the world . It has an exemplary regulatory record when it comes to successful completion of audits from USFDA , AGES , MHRA , ANVISA , WHO , NPA , ANSM , MCC , DCGI & NPRA . Due to stringent quality norms and transparency at all stages , Veeda is considered to be a preferred partner for many
54
BioVoiceNews | November / December 2023